1. Home
  2. ARCT vs NDMO Comparison

ARCT vs NDMO Comparison

Compare ARCT & NDMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • NDMO
  • Stock Information
  • Founded
  • ARCT 2013
  • NDMO 2019
  • Country
  • ARCT United States
  • NDMO United States
  • Employees
  • ARCT N/A
  • NDMO N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • NDMO Trusts Except Educational Religious and Charitable
  • Sector
  • ARCT Health Care
  • NDMO Finance
  • Exchange
  • ARCT Nasdaq
  • NDMO Nasdaq
  • Market Cap
  • ARCT 602.7M
  • NDMO 661.7M
  • IPO Year
  • ARCT N/A
  • NDMO N/A
  • Fundamental
  • Price
  • ARCT $20.60
  • NDMO $11.15
  • Analyst Decision
  • ARCT Strong Buy
  • NDMO
  • Analyst Count
  • ARCT 7
  • NDMO 0
  • Target Price
  • ARCT $65.00
  • NDMO N/A
  • AVG Volume (30 Days)
  • ARCT 338.5K
  • NDMO 218.6K
  • Earning Date
  • ARCT 11-12-2024
  • NDMO 01-01-0001
  • Dividend Yield
  • ARCT N/A
  • NDMO 6.75%
  • EPS Growth
  • ARCT N/A
  • NDMO N/A
  • EPS
  • ARCT N/A
  • NDMO N/A
  • Revenue
  • ARCT $163,866,000.00
  • NDMO N/A
  • Revenue This Year
  • ARCT $13.46
  • NDMO N/A
  • Revenue Next Year
  • ARCT $5.17
  • NDMO N/A
  • P/E Ratio
  • ARCT N/A
  • NDMO N/A
  • Revenue Growth
  • ARCT N/A
  • NDMO N/A
  • 52 Week Low
  • ARCT $17.52
  • NDMO $8.99
  • 52 Week High
  • ARCT $45.00
  • NDMO $11.24
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 42.91
  • NDMO 52.77
  • Support Level
  • ARCT $20.00
  • NDMO $11.07
  • Resistance Level
  • ARCT $21.86
  • NDMO $11.22
  • Average True Range (ATR)
  • ARCT 1.49
  • NDMO 0.10
  • MACD
  • ARCT -0.35
  • NDMO -0.02
  • Stochastic Oscillator
  • ARCT 18.04
  • NDMO 25.00

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.

About NDMO Nuveen Dynamic Municipal Opportunities Fund of Beneficial Interest

Nuveen Dynamic Municipal Opportunities is a closed-end management investment company. The investment objective of the Fund is to seek total return through income exempt from regular federal income taxes and capital appreciation.

Share on Social Networks: